Literature DB >> 19265133

Expression of ADAM33 is a novel regulatory mechanism in IL-18-secreted process in gastric cancer.

Kyung-Eun Kim1, Hyunkeun Song, Candace Hahm, Sun Young Yoon, Sunyoung Park, Ha-reum Lee, Dae Young Hur, Taesung Kim, Cherl-hyun Kim, Sa Ik Bang, Jung-Wook Bang, Hyunjeong Park, Dae-Ho Cho.   

Abstract

IL-18 has recently been reported to play a critical role in tumor migration, invasion, and metastasis. Because IL-18 has various biological activities after its secretion as an 18 kDa mature form, the regulation of the IL-18 secretion process is an important step in tumor progression. This study investigated the implication of IL-18 in vascular endothelial growth factor (VEGF)-D-regulated migration, along with the role of the IL-18 secretion process. VEGF-D enhanced cell migration, which was then blocked by inhibiting IL-18. VEGF-D increased IL-18 expression and secretion, suggesting that IL-18 is a critical mediator for VEGF-D-enhanced migration. VEGF-D induced a disintegrin and metalloprotease 33 (ADAM33) expression, which has a metalloproteinase domain. VEGF-D-enhanced IL-18 secretion and cell migration were inhibited by ADAM33 knock-down. Moreover, cell proliferation was considerably reduced in ADAM33 small interfering RNA transfectants. In conclusion, ADAM33 has a key role in gastric cancer pathogenesis by up-regulating IL-18 secretion process, resulting in increased cell migration and proliferation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19265133     DOI: 10.4049/jimmunol.0801695

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  IL-18 Drives ILC3 Proliferation and Promotes IL-22 Production via NF-κB.

Authors:  Aaron R Victor; Ansel P Nalin; Wenjuan Dong; Susan McClory; Min Wei; Charlene Mao; Raleigh D Kladney; Youssef Youssef; Wing Keung Chan; Edward L Briercheck; Tiffany Hughes; Steven D Scoville; Jason R Pitarresi; Charlie Chen; Sarah Manz; Lai-Chu Wu; Jianying Zhang; Michael C Ostrowski; Aharon G Freud; Gustavo W Leone; Michael A Caligiuri; Jianhua Yu
Journal:  J Immunol       Date:  2017-08-25       Impact factor: 5.422

2.  A Transcriptome-Wide Association Study Identifies Candidate Susceptibility Genes for Pancreatic Cancer Risk.

Authors:  Duo Liu; Dan Zhou; Yanfa Sun; Jingjing Zhu; Dalia Ghoneim; Chong Wu; Qizhi Yao; Eric R Gamazon; Nancy J Cox; Lang Wu
Journal:  Cancer Res       Date:  2020-09-09       Impact factor: 12.701

Review 3.  Molecular background of the regional lymph node metastasis of gastric cancer.

Authors:  Tong Zhu; Xueqian Hu; Pinkang Wei; Guangzhi Shan
Journal:  Oncol Lett       Date:  2018-01-16       Impact factor: 2.967

Review 4.  Fueling the Fire: Inflammatory Forms of Cell Death and Implications for Cancer Immunotherapy.

Authors:  Sheera R Rosenbaum; Nicole A Wilski; Andrew E Aplin
Journal:  Cancer Discov       Date:  2021-01-15       Impact factor: 38.272

5.  The role of interleukin-18 in glioblastoma pathology implies therapeutic potential of two old drugs-disulfiram and ritonavir.

Authors:  Richard E Kast
Journal:  Chin J Cancer       Date:  2015-04-09

Review 6.  Interleukin-18 and IL-18 binding protein.

Authors:  Charles A Dinarello; Daniela Novick; Soohyun Kim; Gilles Kaplanski
Journal:  Front Immunol       Date:  2013-10-08       Impact factor: 7.561

7.  Immunohistochemical study on ADAM33 in sinonasal inverted papillomas and squamous cell carcinomas of the larynx.

Authors:  Olga Stasikowska-Kanicka; Małgorzata Wągrowska-Danilewicz; Marian Danilewicz
Journal:  Arch Med Sci       Date:  2016-02-02       Impact factor: 3.318

8.  Upregulation of a disintegrin and metalloproteinase-33 by VEGF in human airway smooth muscle cells: Implications for asthma.

Authors:  Qing-Mei Pei; Ping Jiang; Min Yang; Xue-Jiao Qian; Jiang-Bo Liu; Hong Zheng; Li-Hong Zhao; Sung-Ho Kim
Journal:  Cell Cycle       Date:  2016-08-11       Impact factor: 4.534

9.  ADAM9 Expression Is Associate with Glioma Tumor Grade and Histological Type, and Acts as a Prognostic Factor in Lower-Grade Gliomas.

Authors:  Xing Fan; Yongheng Wang; Chuanbao Zhang; Li Liu; Sen Yang; Yinyan Wang; Xing Liu; Zenghui Qian; Shengyu Fang; Hui Qiao; Tao Jiang
Journal:  Int J Mol Sci       Date:  2016-08-26       Impact factor: 5.923

10.  NLRP3 Inflammasome Promotes the Progression of Acute Myeloid Leukemia via IL-1β Pathway.

Authors:  Chaoqin Zhong; Ruiqing Wang; Mingqiang Hua; Chen Zhang; Fengjiao Han; Miao Xu; Xinyu Yang; Guosheng Li; Xiang Hu; Tao Sun; Chunyan Ji; Daoxin Ma
Journal:  Front Immunol       Date:  2021-06-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.